Stream Dx: accurate and efficient, point-of-care uroflometry for improved diagnosis, monitoring, and post-treatment evaluation of LUTS
Award amount
$1,493,493Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- STREAM DX, INC
- Proposal award date
- 2017-04-03
- Contract end date
- 2020-01-31
- UEI
- HVDUCDJQ2V95
- Solicitation number
- PAR14-088
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
2 SBIR/STTR records share this UEI (2017–2019). Reported award amounts total $4,464,557. Reported amounts are not federal obligations.
Phases: Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services